Learn more

UCB BIOPHARMA SPRL

Overview
  • Total Patents
    1,520
  • GoodIP Patent Rank
    1,188
  • Filing trend
    ⇩ 22.0%
About

UCB BIOPHARMA SPRL has a total of 1,520 patent applications. It decreased the IP activity by 22.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are MEDAREX INC, BEIJING HANMI PHARMACEUTICAL CO LTD and IMCLONE SYSTEMS INC.

Patent filings per year

Chart showing UCB BIOPHARMA SPRLs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Humphreys David Paul 143
#2 Tyson Kerry Louise 115
#3 Heywood Sam Philip 107
#4 Kroeplien Boris 99
#5 Porter John Robert 98
#6 Adams Ralph 95
#7 Rapecki Stephen Edward 90
#8 Finney Helene Margaret 89
#9 Jackson Victoria Elizabeth 87
#10 Wright Michael John 87

Latest patents

Publication Filing date Title
GB202019702D0 Therapeutic agents
GB202012991D0 Cell culture processes
GB202012501D0 Therapeutic agents
GB202010606D0 Therapeutic agents
GB202010607D0 Therapeutic agents
GB202004462D0 Antibody fragments
GB202001447D0 Antibodies
GB201919213D0 Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds
GB201919214D0 Tetrahydrobenzo-quinoline sulfonamide derivatives useful as IGE modulators
GB201919212D0 Dihydro-cyclopenta-isoquinoline sulfonamides derivatives
GB201919061D0 Multi-specific antibody
GB201919062D0 Antibody
GB201919058D0 Multi-specific antibodies
GB201913759D0 Therapeutic agents
GB201911865D0 Therapeutic agents
GB201909191D0 Therapeutic agents
GB201909194D0 Therapeutic agents
GB201909190D0 Therapeutic agents
WO2019226753A1 Benzodiazepine formulations
GB201906835D0 Dry microparticles